車車集團公司
US ˙ NasdaqCM ˙ KYG207071088

簡介

本頁面提供了有關 N Anthony Coles 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示N Anthony Coles已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:REGN / Regeneron Pharmaceuticals, Inc. Director 1,714
US:CERE / Cerevel Therapeutics Holdings, Inc. Director 0
US:YMTX / Yumanity Therapeutics Inc Executive Chair, Director 78,650
US:MCK / McKesson Corporation Director 0
US:CRSP / CRISPR Therapeutics AG Director 15,000
US:ONXX / Onyx Pharmaceuticals Inc Chairman & CEO, Director 0
US:CCG / Cheche Group Inc. Director 3,999
US:LH / Labcorp Holdings Inc. Director 2,584
如何解讀這些圖表

以下圖表顯示了在N Anthony Coles進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

CCG / Cheche Group Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 CCG / Cheche Group Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

CCG / Cheche Group Inc. Insider Trades
CCG / Cheche Group Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 CCG / Cheche Group Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

CCG / Cheche Group Inc. Insider Trades
歷史內部人交易

該表格顯示了由 N Anthony Coles 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-01-06 2026-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 155 1,714 9.94
2025-01-06 2025-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 166 1,559 11.92
2024-08-05 2024-08-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
D - Sale to Issuer -10,290 0 -100.00
2024-08-05 2024-08-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
D - Sale to Issuer -15,638 10,290 -60.31
2024-07-03 2024-07-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -25,000 25,928 -49.09 41.18 -1,029,535 1,067,751
2024-07-03 2024-07-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 25,000 50,928 96.42 3.50 87,500 178,248
2024-06-07 2024-06-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
A - Award 10,290 25,928 65.80
2024-06-05 2024-06-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 15,638 -76.18 40.61 -2,030,520 635,065
2024-06-05 2024-06-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 65,638 319.73 3.50 175,000 229,733
2024-05-14 2024-05-10 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 15,638 -76.18 42.10 -2,105,125 658,399
2024-05-14 2024-05-10 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 65,638 319.73 3.50 175,000 229,733
2024-04-03 2024-04-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 15,638 -76.18 42.33 -2,116,640 662,000
2024-04-03 2024-04-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 65,638 319.73 3.50 175,000 229,733
2024-03-06 2024-03-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 15,638 -76.18 41.01 -2,050,550 641,330
2024-03-06 2024-03-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 65,638 319.73 3.50 175,000 229,733
2024-03-04 2024-02-29 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 15,638 -76.18 41.16 -2,057,890 643,626
2024-03-04 2024-02-29 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 65,638 319.73 3.50 175,000 229,733
2024-02-08 2024-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale -2,506 15,638 -13.81 41.54 -104,110 649,667
2024-02-08 2024-02-06 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise 15,440 18,144 571.01
2024-01-04 2024-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 135 1,393 10.73
2024-01-04 2024-01-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 2,704 -94.87 42.24 -2,111,815 114,207
2024-01-04 2024-01-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-11-16 2023-11-14 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -22,824 2,704 -89.41 25.13 -573,455 67,938
2023-11-16 2023-11-14 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 22,824 25,528 844.08 3.50 79,884 89,348
2023-11-09 2023-11-08 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -100 2,704 -3.57 25.16 -2,516 68,033
2023-11-09 2023-11-08 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 100 2,804 3.70 3.50 350 9,814
2023-11-09 2023-11-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -27,076 2,704 -90.92 25.02 -677,555 67,665
2023-11-09 2023-11-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 27,076 29,780 1,001.33 3.50 94,766 104,230
2023-11-06 2023-11-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -61,401 2,704 -95.78 25.43 -1,561,458 68,764
2023-11-06 2023-11-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 61,401 64,105 2,270.75 3.50 214,904 224,368
2023-11-06 2023-11-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -38,599 2,704 -93.45 25.19 -972,239 68,109
2023-11-06 2023-11-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 38,599 41,303 1,427.48 3.50 135,096 144,560
2023-09-08 2023-09-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 2,704 -94.87 24.07 -1,203,415 65,081
2023-09-08 2023-09-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-07-13 2023-07-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 2,704 -94.87 30.03 -1,501,340 81,192
2023-07-13 2023-07-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-06-05 2023-06-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 2,704 -94.87 32.60 -1,630,070 88,154
2023-06-05 2023-06-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -300 2,704 -9.99 32.93 -9,879 89,043
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -12,132 3,004 -80.15 31.76 -385,287 95,401
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -37,568 15,136 -71.28 31.36 -1,178,268 474,719
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-04-13 2023-04-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 2,704 -94.87 25.06 -1,253,130 67,769
2023-04-13 2023-04-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-03-06 2023-03-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -3,000 2,704 -52.59 27.19 -81,570 73,522
2023-03-06 2023-03-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 3,000 5,704 110.95 3.50 10,500 19,964
2023-03-06 2023-03-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -47,000 2,704 -94.56 27.11 -1,274,377 73,317
2023-03-06 2023-03-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 47,000 49,704 1,738.17 3.50 164,500 173,964
2023-02-08 2023-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -7,942 2,704 -74.60 33.57 -266,649 90,785
2023-02-08 2023-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -42,058 10,646 -79.80 33.04 -1,389,752 351,783
2023-02-08 2023-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-01-06 2023-01-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -500 2,704 -15.61 30.73 -15,366 83,099
2023-01-06 2023-01-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -49,500 3,204 -93.92 29.93 -1,481,505 95,894
2023-01-06 2023-01-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-01-05 2023-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 165 1,258 15.10
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -311 1,093 -22.15 716.08 -222,701 782,675
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,266 1,404 -61.74 715.48 -1,621,278 1,004,534
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,022 3,670 -21.78 714.61 -730,331 2,622,619
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,198 4,692 -20.34 713.66 -854,965 3,348,493
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 5,890 -1.67 711.95 -71,195 4,193,386
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -679 5,990 -10.18 710.63 -482,518 4,256,674
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1 6,669 -0.01 709.92 -710 4,734,456
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -181 6,670 -2.64 707.87 -128,124 4,721,493
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,613 6,851 111.58 482.68 1,743,923 3,306,841
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,145 3,238 196.25 374.12 802,487 1,211,401
2022-12-13 2022-12-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -5,145 2,704 -65.55 27.09 -139,395 73,260
2022-12-13 2022-12-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -44,855 7,849 -85.11 26.62 -1,193,906 208,917
2022-12-13 2022-12-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -602 1,093 -35.52 584.57 -351,911 638,935
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,045 1,695 -38.14 583.16 -609,402 988,456
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,220 2,740 -30.81 582.56 -710,723 1,596,214
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -822 3,960 -17.19 581.44 -477,944 2,302,502
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -688 4,782 -12.58 580.44 -399,343 2,775,664
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -550 5,470 -9.14 579.85 -318,918 3,171,780
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -273 6,020 -4.34 578.25 -157,862 3,481,065
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -500 6,293 -7.36 577.07 -288,535 3,631,502
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,784 6,793 125.76 371.40 1,405,378 2,522,920
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 3,009 -9.07 576.73 -173,019 1,735,381
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,216 3,309 202.74 374.12 829,050 1,237,963
2022-02-11 2022-02-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 425,772 425,772
2022-01-05 2022-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 2,707 2,707
2022-01-05 2022-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 191 1,093 21.18
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -6,909 0 -100.00
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5,039 0 -100.00
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,174 902 -56.55 664.32 -779,912 599,217
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -905 2,076 -30.36 663.73 -600,676 1,377,903
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3 2,981 -0.10 662.55 -1,988 1,975,062
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,344 2,984 -52.84 661.56 -2,212,257 1,974,095
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -448 6,328 -6.61 660.78 -296,029 4,181,416
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 6,776 -4.24 659.00 -197,700 4,465,384
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -935 7,076 -11.67 658.65 -615,838 4,660,607
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -835 8,011 -9.44 657.53 -549,038 5,267,473
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,400 8,846 -13.66 656.48 -919,072 5,807,222
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -403 10,246 -3.78 655.14 -264,021 6,712,564
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -800 10,649 -6.99 653.31 -522,648 6,957,098
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,101 11,449 -8.77 652.95 -718,898 7,475,625
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 12,550 -2.33 651.36 -195,408 8,174,568
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,039 12,850 64.51 345.47 1,740,823 4,439,290
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,909 7,811 765.96 380.95 2,631,984 2,975,600
2021-08-19 2021-08-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5,100 5,039 -50.30
2021-08-19 2021-08-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,100 902 -84.97 650.00 -3,315,000 586,300
2021-08-19 2021-08-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,100 6,002 565.41 345.47 1,761,897 2,073,511
2021-08-19 2021-08-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -900 10,139 -8.15
2021-08-19 2021-08-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -900 902 -49.94 650.00 -585,000 586,300
2021-08-19 2021-08-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 900 1,802 99.78 345.47 310,923 622,537
2021-08-16 2021-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -2,000 11,039 -15.34
2021-08-16 2021-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 902 -68.92 625.00 -1,250,000 563,750
2021-08-16 2021-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,000 2,902 221.73 345.47 690,940 1,002,554
2021-04-02 2021-04-01 4 YMTX YUMANITY THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 78,650 78,650
2021-02-05 2021-02-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 732,714 732,714
2021-02-03 2021-02-01 4 YMTX YUMANITY THERAPEUTICS, INC.
Common Stock
A - Award 1,118 691,008 0.16
2021-01-05 2021-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 3,613 3,613
2021-01-05 2021-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 248 902 37.92
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Warrant (Right to Buy)
A - Award 6,038 6,038
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 12,082 12,082
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 72,496 72,496
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Common Stock
A - Award 52,669 52,669
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Common Stock
A - Award 689,890 689,890
2020-11-13 2020-11-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -11 13,039 -0.08
2020-11-13 2020-11-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11 654 1.71 345.47 3,800 225,937
2020-10-30 2020-10-28 4 CERE Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 196,335 196,335
2020-08-19 2020-08-17 4 MCK MCKESSON CORP
Common Stock
S - Sale -2,453 0 -100.00 156.77 -384,559
2020-07-31 2020-07-29 4 MCK MCKESSON CORP
Common Stock
A - Award 1,157 2,453 89.27
2020-01-06 2020-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 4,361 4,361
2020-01-06 2020-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 320 643 99.07
2019-08-01 2019-07-31 4 MCK MCKESSON CORP
Common Stock
A - Award 1,296 1,296
2019-01-04 2019-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 3,784 3,784
2019-01-04 2019-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
A - Award 323 323
2018-09-04 2018-08-31 4 MCK MCKESSON CORP
Common Stock
S - Sale X -1,350 0 -100.00 128.69 -173,732
2018-07-26 2018-07-25 4 MCK MCKESSON CORP
Common Stock
A - Award 1,350 1,350
2018-01-04 2018-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 6,909 6,909
2017-07-27 2017-07-26 4 MCK MCKESSON CORP
Restricted Stock Units (RSUs)
A - Award 1,083 1,083
2017-06-02 2017-05-31 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 15,000 15,000
2017-01-31 2017-01-27 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 13,050 13,050
2016-10-26 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
A - Award 35,000 70,000 100.00 14.00 490,000 980,000
2016-10-26 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
A - Award 35,000 70,000 100.00 14.00 490,000 980,000
2016-10-20 2016-10-18 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 15,000 15,000
2016-07-28 2016-07-27 4 MCK MCKESSON CORP
Restricted Stock Units (RSUs)
A - Award 915 915
2015-07-31 2015-07-29 4 MCK MCKESSON CORP
Restricted Stock Units
A - Award 794 794
2014-07-31 2014-07-30 4 MCK MCKESSON CORP
Restricted Stock Units
A - Award 785 785
2014-05-16 2014-05-15 4 MCK MCKESSON CORP
Restricted Stock Units
A - Award 212 212
2014-05-01 3 MCK MCKESSON CORP
Common Stock
0
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -75,300 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -139,947 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -2,653 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -45,283 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -2,842 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -143,698 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -3,302 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -5,247 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -105,566 0 -100.00 125.00 -13,195,750
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
U - Other -25,632 105,566 -19.54 125.00 -3,204,000 13,195,750
2013-06-07 2013-06-05 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -6,562 48,125 -12.00
2013-06-07 2013-06-05 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -6,562 131,198 -4.76 90.00 -590,580 11,807,820
2013-06-07 2013-06-05 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 6,562 137,760 5.00 35.18 230,851 4,846,397
2013-05-31 2013-04-22 4 CCG Campus Crest Communities, Inc.
Common Stock
D - Sale to Issuer -16,335 3,999 -80.33
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -3,502 5,247 -40.03
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -13,776 0 -100.00
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 3,502 131,198 2.74 28.55 99,982 3,745,703
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 13,776 127,696 12.09 29.03 399,917 3,707,015
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1,300 113,920 -1.13 90.81 -118,053 10,345,075
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -8,405 115,220 -6.80 89.30 -750,566 10,289,146
2013-04-03 2013-04-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -7,859 123,625 -5.98 86.14 -676,974 10,649,058
2013-04-03 2013-04-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -3,770 131,484 -2.79 86.14 -324,748 11,326,032
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 75,300 75,300
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10,938 54,687 -16.67
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 26,800 135,254 24.71
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -10,938 108,454 -9.16 90.00 -984,420 9,760,860
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 10,938 119,392 10.09 35.18 384,799 4,200,211
2013-02-19 2013-02-15 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
G - Gift -216 2,584 -7.71
2013-01-31 2013-01-31 4 CCG Campus Crest Communities, Inc.
Common Stock
A - Award 7,000 20,334 52.50
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -39,375 65,625 -37.50
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -86,224 13,776 -86.22
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -125,599 108,343 -53.69
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 39,375 233,942 20.24 35.18 1,385,212 8,230,080
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 86,224 194,567 79.58 29.03 2,503,083 5,648,280
2012-08-09 2012-08-08 4 ONXX ONYX PHARMACEUTICALS INC
StockOption (Right to Buy)
M - Exercise -250,000 100,000 -71.43
2012-08-09 2012-08-08 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale -270,690 108,343 -71.42 72.18 -19,538,404 7,820,198
2012-08-09 2012-08-08 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 250,000 379,033 193.75 29.03 7,257,500 11,003,328
2012-08-03 2012-08-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -8,820 154,033 -5.42 74.37 -655,943 11,455,434
2012-07-27 2012-07-25 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -11,883 162,853 -6.80 73.97 -879,007 12,046,530
2012-05-29 2012-05-24 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 1,800 2,800 180.00
2012-04-03 2012-04-02 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer X -2,406 174,330 -1.36 36.58 -88,007 6,376,660
2012-04-03 2012-04-02 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer X -3,368 176,736 -1.87 36.58 -123,192 6,464,526
2012-04-03 2012-04-02 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer X -2,406 180,104 -1.32 36.58 -88,004 6,587,646
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 142,600 142,600
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 60,100 182,510 49.10
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 28,000 122,410 29.66
2012-03-29 2012-03-28 4 CCG Campus Crest Communities, Inc.
Common Stock
A - Award 6,667 13,334 100.00
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)